Stocktoria

agilon health, inc. AGL

NYSE · stock · Services-Misc Health & Allied Services, NEC · website · IPO 2021-04-15

agilon health, inc. financials (annual)

Revenue
$1.22B $1.52B $2.39B $4.32B $6.06B $5.93B 202020212022202320242025
Net income
-$60.1M -$406.5M -$106.6M -$262.6M -$260.2M -$391.3M 202020212022202320242025
Free cash flow
-$55.0M -$154.7M -$146.2M -$172.0M -$71.0M -$119.0M 202020212022202320242025

Bars are annual figures from 2020 to 2025; red bars are negative (a loss or cash outflow).

MetricFY2025FY2024FY2023FY2022FY2021FY2020
Revenue$5.9B$6.1B$4.3B$2.4B$1.5B$1.2B
Operating income-$463.2M-$292.1M-$232.1M-$105.4M-$372.2M-$56.7M
Interest expense$6.7M$4.5M$6.1M$8.1M
Income tax$1.3M$1.5M$791,000$1.6M$886,000$865,000
Net income-$391.3M-$260.2M-$262.6M-$106.6M-$406.5M-$60.1M
Operating cash flow-$105.8M-$57.8M-$156.2M-$130.8M-$148.2M-$53.2M
Free cash flow-$119.0M-$71.0M-$172.0M-$146.2M-$154.7M-$55.0M
Cash & equivalents$173.7M$188.2M$107.6M$465.3M$1.0B$106.8M
Total assets$1.3B$1.7B$1.7B$1.7B$1.6B$446.4M
Total liabilities$1.1B$1.3B$1.1B$656.9M$494.7M$421.6M
Shareholders' equity$126.7M$471.0M$661.8M$1.0B$1.1B-$284.7M

Growth · year-over-year · Revenue CAGR 37.2%

MetricFY2025FY2024FY2023FY2022FY2021FY2020
Revenue growth-2.1%+40.4%+80.7%+57.0%+24.9%

Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.